UBS Group’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,315
| Closed | -$2.3K | – | 10424 |
|
|
2023
Q1 | $2.3K | Buy |
1,315
+323
| +33% | +$543 | ﹤0.01% | 8535 |
|
|
2022
Q4 | $1.88K | Buy |
992
+611
| +160% | +$1.35K | ﹤0.01% | 9775 |
|
|
2022
Q3 | $1K | Sell |
381
-886
| -70% | -$3.73K | ﹤0.01% | 10251 |
|
|
2022
Q2 | $6K | Buy |
1,267
+36
| +3% | +$235 | ﹤0.01% | 8819 |
|
|
2022
Q1 | $13K | Buy |
+1,231
| New | +$15K | ﹤0.01% | 8139 |
|
|
2020
Q2 | – | Sell |
-22
| Closed | -$3K | – | 8618 |
|
|
2020
Q1 | $3K | Buy |
+22
| New | +$6.73K | ﹤0.01% | 7569 |
|
|
2019
Q4 | – | Sell |
-28
| Closed | -$14K | – | 8616 |
|
|
2019
Q3 | $14K | Sell |
28
-18
| -39% | -$10.2K | ﹤0.01% | 6977 |
|
|
2019
Q2 | $28K | Buy |
46
+5
| +12% | +$3.07K | ﹤0.01% | 6398 |
|
|
2019
Q1 | $25K | Sell |
41
-109
| -73% | -$59.5K | ﹤0.01% | 6126 |
|
|
2018
Q4 | $55K | Buy |
150
+100
| +200% | +$53.8K | ﹤0.01% | 6013 |
|
|
2018
Q3 | $34K | Sell |
50
-30
| -38% | -$21.3K | ﹤0.01% | 6454 |
|
|
2018
Q2 | $69K | Buy |
80
+9
| +13% | +$10.3K | ﹤0.01% | 5742 |
|
|
2018
Q1 | $90K | Buy |
71
+52
| +274% | +$76.9K | ﹤0.01% | 5287 |
|
|
2017
Q4 | $29K | Buy |
19
+14
| +280% | +$22.1K | ﹤0.01% | 6275 |
|
|
2017
Q3 | $10K | Buy |
+5
| New | +$11.7K | ﹤0.01% | 6913 |
|
|
2017
Q1 | – | Sell |
-5
| Closed | -$7K | – | 8149 |
|
|
2016
Q4 | $7K | Buy |
+5
| New | +$6.64K | ﹤0.01% | 7116 |
|
|
2016
Q2 | – | Sell |
-5
| Closed | -$12K | – | 8092 |
|
|
2016
Q1 | $12K | Hold |
5
| – | – | ﹤0.01% | 6558 |
|
|
2015
Q4 | $13K | Buy |
+5
| New | +$12.2K | ﹤0.01% | 7137 |
|
Other funds holding NBRV
VFA
AWM
AA